查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1751249

放射腫瘤學市場規模、佔有率、趨勢分析報告（按類型、技術、應用、地區、細分市場預測），2025 年至 2030 年

Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

放射腫瘤學市場的成長和趨勢：

根據Grand View Research, Inc.的最新報告，全球放射腫瘤學市場規模預計到2030年將達到211.9億美元，2025年至2030年期間的複合年成長率為11.17%。

市場的成長歸因於全球癌症負擔的增加、老年人口的成長以及政府和私人機構實施的支持性報銷計劃。此外，放射治療技術的不斷創新和進步也為市場成長提供了豐厚的利潤機會。

在全球範圍內，癌症患者的發生率不斷上升，這是推動放射腫瘤學市場成長的主要因素。例如，根據Globocan的數據，2020年將有超過2,000萬人被診斷出罹患癌症，並將有1,000萬人死於癌症。此外，由於免疫力下降和合併症，老齡化社會導致癌症風險更高。因此，老年人口的成長進一步推動了市場的成長。例如，根據世界衛生組織的估計，2020年全球老年人口約為10億，預計2050年將達到21億人。

為開發新型放射治療技術和多學科治療方法而進行的廣泛研究活動有望​​提高癌症患者的存活率並改善預後。例如，2022年12月，Elekta Unity展示了磁振造影直線加速器（MR-Linac）在胰臟腫瘤治療中的應用，並首次為歷史上首位患者採用了新型先進放射治療運動管理技術。

同樣在2020年6月，Isoray與辛辛那提大學醫師公司簽署了一項協議，以研究頸部和頭部癌症的治療。兩家公司將評估Keytruda與銫-131合併用於手術切除後的療效。此類醫用同位素在癌症治療中的應用可能有助於了解疾病的複雜性和患者的需求，並促進新型特異性放射治療系統的研究開發。

此外，針對放射治療的支持性報銷和監管政策也有望推動放射腫瘤學市場的成長。例如，2021年7月，美國醫療保險和醫療補助服務中心 (CMS) 針對癌症診斷和放射治療服務制定了新的放射腫瘤學支付模式 (RO-APM)，這將提高患者護理品質並減少年度醫療保險支出。

放射腫瘤學市場報告重點

  • 由於線性加速器(LINAC)、微型先進收益佔有率系統等在治療各種癌症方面的應用日益廣泛，體外放射治療(EBRT) 市場在 2024 年佔據了整個市場中最大的收入佔有率。
  • 2024 年，IMRT 部門佔據了最大的收益佔有率，為 24.06%，這歸因於治療需求巨大的以及治療需求未得到滿足的國家中技術先進的強度調控放射治療(IMRT) 的日益普及。
  • 前列腺癌 EBRT 領域在 2024 年佔據最大收益佔有率，為 58.65%，預計在預測期內仍將保持主導地位。
  • 由於癌症發生率的上升和新興市場產品採用率的提高，IBRT 市場預計在預測期內將顯著成長。
  • 由於政府的有利舉措和技術先進的放射治療設備，北美放射腫瘤學產業在 2024 年佔據全球收益佔有率%。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章放射腫瘤學市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場趨勢與展望
  • 市場動態
    • 增加放射治療的使用
    • 放射治療技術的進步
    • 癌症發生率上升
    • 醫療成本上漲
    • 擴大放射性藥物的應用
  • 市場限制因素分析
    • 熟練放射治療師短缺
    • 輻射基礎設施不足
    • 放射線治療副作用類型分析工具
    • 波特五力分析
    • PESTEL分析

第4章放射腫瘤學市場：按類型估計和趨勢分析

  • 放射腫瘤學市場：按類型變化分析
  • 按類型
  • 體外放射線治療
    • 線性加速器（linac）
    • 緊湊型先進放射治療系統
    • 質子治療
  • 內部放射治療
    • 放射線治療
    • 全身放射線治療
    • 其他

第5章放射腫瘤學市場：按技術分類的估計和趨勢分析

  • 放射腫瘤學市場：依技術分類的差異分析
  • 依技術
  • 體外放射線治療
    • 影像導航放射治療(IGRT)
    • 強度調控放射治療(IMRT)
    • 立體定位放射治療技術
    • 質子治療
    • 3D適形放射治療（3D CRT）
    • 容積調強弧形治療 (VMAT)
  • 放射線治療
    • 低劑量近距離放射治療
    • 高劑量近距離放射治療

第6章放射腫瘤學市場：按應用的估計和趨勢分析

  • 放射腫瘤學市場：按應用進行的變化分析
  • 按用途
  • 體外放射線治療
    • 攝護腺癌
    • 乳癌
    • 肺癌
    • 頭頸癌
    • 大腸直腸癌
    • 其他
  • 內部放射治療
    • 攝護腺癌
    • 乳癌
    • 肺癌
    • 頭頸癌
    • 大腸直腸癌
    • 其他

第7章放射腫瘤學市場：區域估計和趨勢分析

  • 2024 年及 2030 年各地區放射腫瘤學市場佔有率
  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場概況
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 2018-2030年北美放射腫瘤學市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲放射腫瘤學市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區放射腫瘤學市場
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030年拉丁美洲放射腫瘤學市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年中東及非洲放射腫瘤學市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 戰略地圖
  • 2024年公司市場佔有率分析
  • 公司簡介
    • Varian Medical Systems, Inc.
    • Elekta AB
    • Accuray Incorporated
    • IBA Radiopharma Solutions
    • BD（Becton, Dickinson and Company）
    • Isoray Inc.
    • Mevion Medical Systems
    • Nordion, Inc.
    • NTP Radioisotopes SOC Ltd.
    • Curium
    • ViewRay Technologies, Inc.
Product Code: GVR-1-68038-801-5

Radiation Oncology Market Growth & Trends:

The global radiation oncology market size is expected to reach USD 21.19 billion in 2030 and is projected to grow at a CAGR of 11.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the global rise in cancer burden, the growing geriatric population, and supportive reimbursement programs undertaken by the government and private organizations. Furthermore, the increasing technological innovation and advancement in radiotherapy offer lucrative opportunities for market growth.

The world is witnessing an increasing prevalence of cancer cases which is the key factor driving the radiation oncology market growth. For instance, according to Globocan, in 2020, more than 20.0 million people were diagnosed with cancer, and 10.0 million died of cancer. Moreover, the aging population is at high risk of cancer due to a weak immune system and comorbid conditions; thereby, the rising geriatric population further fuels market growth. For instance, in 2020, according to WHO estimates, the global geriatric population was approximately 1.0 billion and is expected to reach 2.1 billion by 2050.

Extensive research activities for the development of novel radiotherapy techniques and multidisciplinary therapeutic approaches are expected to lead to an increased survival rate and a more favorable prognosis of cancer. For instance, in December 2022, Elekta Unity demonstrated MR-Linac use for pancreatic tumors, where the first-ever patient was treated with new advanced radiotherapy motion management.

Similarly, in June 2020, Isoray signed a research agreement with the University of Cincinnati Physicians Company to study neck and head cancer treatment. The companies will evaluate the efficacy of Keytruda along with Cesium-131 post-surgical resection. Using such medical isotopes for cancer treatment may boost the research in developing a new target-specific radiation therapy system by understanding disease complexity & patients' need, thereby widening the opportunity in the market.

Furthermore, supportive reimbursement and regulatory policies for radiation therapy are also expected to drive the radiation oncology market growth. For instance, in July 2021, the Centers for Medicare and Medicaid Services (CMS) developed a new Radiation Oncology Payment Model (RO-APM) for the diagnosis of cancer and radiotherapy services. It enhances the quality of care of the patients and reduces the annual Medicare expenditure.

Radiation Oncology Market Report Highlights:

  • The external beam radiation therapy (EBRT) market, which includes linear accelerators (Linac), and compact advanced radiotherapy systems, dominated the overall market with the largest revenue share in 2024 due to increased adoption in the treatment of various types of cancers
  • The IMRT segment held the largest revenue share of 24.06% in 2024, attributed to the substantial demand for treatment and increased availability of technologically advanced intensity-modulated radiotherapy (IMRT) in countries with unmet treatment needs.
  • The EBRT segment for prostate cancer held the largest revenue share of 58.65% in 2024 and is anticipated to maintain its dominance over the forecast period
  • The market for IBRT is anticipated to witness significant growth over the forecast period due to the growing prevalence of cancer in developing countries and increased product penetration
  • North America radiation oncology industry dominated globally in terms of revenue share of 47.16% in 2024, owing to the favorable government initiatives and availability of technologically advanced radiotherapy equipment

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Technology
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Applicationoutlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Radiation Oncology Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Rising adoption of radiotherapy
    • 3.4.2. Technological advancements in radiotherapy
    • 3.4.3. Rising prevalence of cancer
    • 3.4.4. Increase in healthcare expenditure
    • 3.4.5. Increasing application of radiopharmaceuticalsg
  • 3.5. Market Restraint Analysis
    • 3.5.1. Lack Of Skilled Radiotherapy Professionals
    • 3.5.2. Inadequate Radiation Infrastructure
    • 3.5.3. Adverse Effects Of RadiotherapyType Analysis Tools
    • 3.5.4. Porter's Five Forces Analysis
    • 3.5.5. PESTEL Analysis

Chapter 4. Radiation Oncology Market: Type Estimates & Trend Analysis

  • 4.1. Radiation Oncology Market: Type Movement Analysis
  • 4.2. Radiation Oncology Market Estimates and Forecast, by Type
  • 4.3. External Beam Radiation Therapy
    • 4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2. Linear Accelerators (Linac)
      • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.3. Compact advanced radiotherapy systems
      • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.3.2. Cyberknife
        • 4.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.3.3. Gamma Knife
        • 4.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.3.4. Tomotherapy
        • 4.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.4. Proton Therapy
      • 4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.4.2. Cyclotron
        • 4.3.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.4.3. Synchrotron
        • 4.3.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4. Internal Beam Radiation Therapy
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Brachytherapy
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Seeds
        • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Applicators and After loaders
        • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Electronic Brachytherapy
        • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Systemic Beam Radiation Therapy
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Radiation Oncology Market: Technology Estimates & Trend Analysis

  • 5.1. Radiation Oncology Market: Technology Movement Analysis
  • 5.2. Radiation Oncology Market Estimates and Forecast, by Technology
  • 5.3. External Beam Radiation Therapy
    • 5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Image-Guided Radiotherapy (IGRT)
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Intensity Modulated Radiotherapy (IMRT)
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Stereotactic Technology
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Proton Beam Therapy
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.6. 3D Conformal Radiotherapy (3D CRT)
    • 5.3.7. Volumetric Modulated Arc Therapy (VMAT)
      • 5.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Brachytherapy
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Low-Dose Rate Brachytherapy
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. High-Dose Rate Brachytherapy
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Radiation Oncology Market: Application Estimates & Trend Analysis

  • 6.1. Radiation Oncology Market: Application Movement Analysis
  • 6.2. Radiation Oncology Market Estimates and Forecast, by End Use
  • 6.3. External Beam Radiation Therapy
    • 6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Prostate Cancer
      • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Breast Cancer
      • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.4. Lung Cancer
      • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.5. Head and Neck Cancer
      • 6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.6. Colorectal Cancer
      • 6.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.7. Others
      • 6.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Internal Beam Radiation Therapy
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Prostate Cancer
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Breast Cancer
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Lung Cancer
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Head and Neck Cancer
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Colorectal Cancer
      • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Others
      • 6.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Radiation Oncology Market: Regional Estimates & Trend Analysis

  • 7.1. Radiation Oncology Market Share By Region, 2024 & 2030
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Global Regional Market Snapshot
  • 7.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. North America Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. U.S. Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.6.3. Canada
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Canada Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.6.4. Mexico
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Mexico Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.7. Europe
    • 7.7.1. Europe Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.2. UK
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. UK Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.3. Germany
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Germany Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.4. France
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. France Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.5. Italy
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Italy Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.6. Spain
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Spain Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.7. Denmark
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Denmark Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.8. Sweden
      • 7.7.8.1. Key Country Dynamics
      • 7.7.8.2. Competitive Scenario
      • 7.7.8.3. Regulatory Framework
      • 7.7.8.4. Sweden Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.9. Norway
      • 7.7.9.1. Key Country Dynamics
      • 7.7.9.2. Competitive Scenario
      • 7.7.9.3. Regulatory Framework
      • 7.7.9.4. Norway Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.8. Asia Pacific
    • 7.8.1. Asia Pacific Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.2. Japan
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Japan Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.3. China
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. China Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.4. India
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. India Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.5. Australia
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Australia Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.6. Thailand
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Competitive Scenario
      • 7.8.6.3. Regulatory Framework
      • 7.8.6.4. Thailand Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.7. South Korea
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Competitive Scenario
      • 7.8.7.3. Regulatory Framework
      • 7.8.7.4. South Korea Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.9. Latin America
    • 7.9.1. Latin America Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.9.2. Brazil
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Brazil Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.9.3. Argentina
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Argentina Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.10. MEA
    • 7.10.1. MEA Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.2. South Africa
      • 7.10.2.1. Key Country Dynamics
      • 7.10.2.2. Competitive Scenario
      • 7.10.2.3. Regulatory Framework
      • 7.10.2.4. South Africa Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.3. Saudi Arabia
      • 7.10.3.1. Key Country Dynamics
      • 7.10.3.2. Competitive Scenario
      • 7.10.3.3. Regulatory Framework
      • 7.10.3.4. Saudi Arabia Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.4. UAE
      • 7.10.4.1. Key Country Dynamics
      • 7.10.4.2. Competitive Scenario
      • 7.10.4.3. Regulatory Framework
      • 7.10.4.4. UAE Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.5. Kuwait
      • 7.10.5.1. Key Country Dynamics
      • 7.10.5.2. Competitive Scenario
      • 7.10.5.3. Regulatory Framework
      • 7.10.5.4. Kuwait Radiation Oncology Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Strategy Mapping
  • 8.4. Company Market Share Analysis, 2024
  • 8.5. Company Profiles
    • 8.5.1. Varian Medical Systems, Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Elekta AB
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Accuray Incorporated
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. IBA Radiopharma Solutions
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. BD (Becton, Dickinson and Company)
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Isoray Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Mevion Medical Systems
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Nordion, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. NTP Radioisotopes SOC Ltd.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Curium
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. ViewRay Technologies, Inc.
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 3 Global Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 4 Global Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 5 Global Radiation Oncology Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 North America Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 9 North America Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Europe America Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Europe America Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 20 UK Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 UK Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 UK Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 23 Germany Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Germany Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 France Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 France Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 France Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 Italy Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Italy Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 Italy Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 32 Spain Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Spain Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Spain Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Sweden Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Sweden Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Norway Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Norway Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Norway Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 49 Japan Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 Japan Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51 Japan Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 52 China Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 China Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 54 China Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 55 India Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 56 India Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 India Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 Australia Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Australia Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 Australia Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 61 Thailand Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Thailand Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 Thailand Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 South Korea Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70 Latin America Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Brazil Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Mexico Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Argentina Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Radiation Oncology Market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Africa Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 audi Arabia Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 90 UAE Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 UAE Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Radiation Oncology Market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Radiation oncology market: Type movement analysis
  • Fig. 15 Radiation oncology market: Type outlook and key takeaways
  • Fig. 16 External Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 17 Linear Accelerators (Linac) market estimates and forecast, 2018 - 2030
  • Fig. 18 Compact advanced radiotherapy systems market estimates and forecast, 2018 - 2030
  • Fig. 19 Cyberknife market estimates and forecast, 2018 - 2030
  • Fig. 20 Gamma Knife market estimates and forecast, 2018 - 2030
  • Fig. 21 Tomotherapy market estimates and forecast, 2018 - 2030
  • Fig. 22 Proton Therapy market estimates and forecast, 2018 - 2030
  • Fig. 23 Cyclotron market estimates and forecast, 2018 - 2030
  • Fig. 24 Synchrotron market estimates and forecast, 2018 - 2030
  • Fig. 25 Internal Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 26 Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 27 Seeds market estimates and forecast, 2018 - 2030
  • Fig. 28 Applicators and After loaders market estimates and forecast, 2018 - 2030
  • Fig. 29 Electronic Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 30 Systemic Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Radiation oncology market: Technology movement analysis
  • Fig. 33 Radiation oncology market: Technology outlook and key takeaways
  • Fig. 34 External Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 35 Image-Guided Radiotherapy (IGRT) market estimates and forecast, 2018 - 2030
  • Fig. 36 Intensity Modulated Radiotherapy (IMRT) market estimates and forecast, 2018 - 2030
  • Fig. 37 Stereotactic Technology market estimates and forecast, 2018 - 2030
  • Fig. 38 Proton Beam Therapy market estimates and forecast, 2018 - 2030
  • Fig. 39 3D Conformal Radiotherapy (3D CRT) market estimates and forecast, 2018 - 2030
  • Fig. 40 Volumetric Modulated Arc Therapy (VMAT) market estimates and forecast, 2018 - 2030
  • Fig. 41 Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 42 Low-Dose Rate Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 43 High-Dose Rate Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 44 Radiation oncology market: Application movement analysis
  • Fig. 45 Radiation oncology market: Application outlook and key takeaways
  • Fig. 46 External Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 47 Prostate Cancer market estimates and forecast, 2018 - 2030
  • Fig. 48 Breast Cancer market estimates and forecast, 2018 - 2030
  • Fig. 49 Lung Cancer market estimates and forecast, 2018 - 2030
  • Fig. 50 Head and Neck Cancer market estimates and forecast, 2018 - 2030
  • Fig. 51 Colorectal Cancer market estimates and forecast, 2018 - 2030
  • Fig. 52 Others market estimates and forecast, 2018 - 2030
  • Fig. 53 Internal Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 54 Prostate Cancer market estimates and forecast, 2018 - 2030
  • Fig. 55 Gynecological Cancer market estimates and forecast, 2018 - 2030
  • Fig. 56 Cervical Cancer market estimates and forecast, 2018 - 2030
  • Fig. 57 Breast Cancer market estimates and forecast, 2018 - 2030
  • Fig. 58 Penile Cancer market estimates and forecast, 2018 - 2030
  • Fig. 59 Others market estimates and forecast, 2018 - 2030
  • Fig. 60 Regional outlook, 2024 & 2030
  • Fig. 61 Global Radiation Oncology Market: Region movement analysis
  • Fig. 62 North America Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 63 U.S. Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 64 Canada Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 65 Mexico Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 66 Europe Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 67 Germany Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 68 UK Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 69 France Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 70 Italy Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 71 Spain Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 72 Denmark Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 73 Sweden Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 74 Norway Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 76 Japan Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 77 China Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 78 India Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 79 Australia Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 81 Thailand Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 84 Argentina Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 85 Middle East and Africa Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 87 Saudi Arabia Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 88 UAE Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait Radiation Oncology Market, 2018 - 2030 (USD Million)